Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00027074

Ligand	Ligand name	Chain	PDB	Tanimoto
QGA	1-[(3-CYCLOHEXYLPROPANOYL)(2-HYDROXYETHYL)AMINO]-1-DEOXY-D-ALLITOL	A,B	2JGQ	0.71
IHN	N-(3-methylbutanoyl)-L-valyl-N-[(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)-2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)-1-methyl-2-oxoethyl]amino}-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-valinamide	A	3EMY	0.71
IHN	N-(3-methylbutanoyl)-L-valyl-N-[(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)-2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)-1-methyl-2-oxoethyl]amino}-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-valinamide	A	2H6T	0.71
IHN	N-(3-methylbutanoyl)-L-valyl-N-[(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)-2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)-1-methyl-2-oxoethyl]amino}-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-valinamide	A,B	1LS5	0.71
IHN	N-(3-methylbutanoyl)-L-valyl-N-[(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)-2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)-1-methyl-2-oxoethyl]amino}-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-valinamide	A,B	1SME	0.71
IHN	N-(3-methylbutanoyl)-L-valyl-N-[(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)-2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)-1-methyl-2-oxoethyl]amino}-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-valinamide	A,C	1W6I	0.71
IHN	N-(3-methylbutanoyl)-L-valyl-N-[(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)-2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)-1-methyl-2-oxoethyl]amino}-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-valinamide	A,B	1XDH	0.71
IHN	N-(3-methylbutanoyl)-L-valyl-N-[(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)-2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)-1-methyl-2-oxoethyl]amino}-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-valinamide	A,B	2QZX	0.71
IHN	N-(3-methylbutanoyl)-L-valyl-N-[(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)-2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)-1-methyl-2-oxoethyl]amino}-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-valinamide	A	1IZE	0.71
IHN	N-(3-methylbutanoyl)-L-valyl-N-[(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)-2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)-1-methyl-2-oxoethyl]amino}-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-valinamide	A,B	1M43	0.71
NAY	6,7,8,9-TETRAHYDROXY-5-METHYLCARBOXAMIDO-2-OXONONANOIC ACID	A,C	1F74	0.71
AB9	(2R)-4-AMINO-N-{(1R,2S,3R,4R,5S)-5-AMINO-2-{2-[(2-AMINOETHYL)AMINO]ETHOXY}-4-[(2,6-DIAMINO-2,6-DIDEOXY-ALPHA-D-GLUCOPYRANOSYL)OXY]-3-HYDROXYCYCLOHEXYL}-2-HYDROXYBUTANAMIDE	A,D,M,N,Z	2F4V	0.71
AB9	(2R)-4-AMINO-N-{(1R,2S,3R,4R,5S)-5-AMINO-2-{2-[(2-AMINOETHYL)AMINO]ETHOXY}-4-[(2,6-DIAMINO-2,6-DIDEOXY-ALPHA-D-GLUCOPYRANOSYL)OXY]-3-HYDROXYCYCLOHEXYL}-2-HYDROXYBUTANAMIDE	B	2F4T	0.71
FEB	N~2~-[(3R)-3-hydroxydodecanoyl]-L-asparaginyl-N~1~-[(1S)-1-(hydroxymethyl)-3-methylbutyl]-L-glutamamide	2,H,K,N,V,Y	3D29	0.71
AR9	(2R,4S)-N-butyl-4-[(2S,5S,7R)-2,7-dimethyl-3,15-dioxo-1,4-diazacyclopentadecan-5-yl]-4-hydroxy-2-methylbutanamide	A,B,C	3DV1	0.74
ATI	N-(3-AMINO-2-HYDROXY-5-METHYLHEXANOYL)VALYLVALYLASPARTIC ACID	A	1Y0Y	0.71
U0E	N-[[1-[N-ACETAMIDYL]-[1-CYCLOHEXYLMETHYL-2-HYDROXY-4-ISOPROPYL]-BUT-4-YL]-CARBONYL]-GLUTAMINYL-ARGINYL-AMIDE	B	1GNO	0.7
U0E	N-[[1-[N-ACETAMIDYL]-[1-CYCLOHEXYLMETHYL-2-HYDROXY-4-ISOPROPYL]-BUT-4-YL]-CARBONYL]-GLUTAMINYL-ARGINYL-AMIDE	B	1A9M	0.7
U0E	N-[[1-[N-ACETAMIDYL]-[1-CYCLOHEXYLMETHYL-2-HYDROXY-4-ISOPROPYL]-BUT-4-YL]-CARBONYL]-GLUTAMINYL-ARGINYL-AMIDE	A	1AXA	0.7
U0E	N-[[1-[N-ACETAMIDYL]-[1-CYCLOHEXYLMETHYL-2-HYDROXY-4-ISOPROPYL]-BUT-4-YL]-CARBONYL]-GLUTAMINYL-ARGINYL-AMIDE	A	1GNM	0.7
U0E	N-[[1-[N-ACETAMIDYL]-[1-CYCLOHEXYLMETHYL-2-HYDROXY-4-ISOPROPYL]-BUT-4-YL]-CARBONYL]-GLUTAMINYL-ARGINYL-AMIDE	A	1GNN	0.7
CPQ	N,N-BIS(3-D-GLUCONAMIDOPROPYL)DEOXYCHOLAMIDE	A	2REW	0.72
CPQ	N,N-BIS(3-D-GLUCONAMIDOPROPYL)DEOXYCHOLAMIDE	A	1IMX	0.72
CPQ	N,N-BIS(3-D-GLUCONAMIDOPROPYL)DEOXYCHOLAMIDE	A	1I7G	0.72
MLD	GLCNAC(BETA1-4)-MURNAC(1,6-ANHYDRO)-L-ALA-GAMMA-D-GLU-MESO-A2PM-D-ALA	A,X	2F2L	0.72
MLD	GLCNAC(BETA1-4)-MURNAC(1,6-ANHYDRO)-L-ALA-GAMMA-D-GLU-MESO-A2PM-D-ALA	A,B,C,D	2CB3	0.72
CR6	1-DEOXY-1-ACETYLAMINO-BETA-D-GLUCO-2-HEPTULOPYRANOSONAMIDE	A	1P4H	0.72
CR6	1-DEOXY-1-ACETYLAMINO-BETA-D-GLUCO-2-HEPTULOPYRANOSONAMIDE	A	1FU8	0.72
MU2	N-ACETYLMURAMYL-L-ALANYL-D-ISOGLUTAMINE	A	2IXV	0.74
MU2	N-ACETYLMURAMYL-L-ALANYL-D-ISOGLUTAMINE	A	2IXU	0.74
NOK	2-ACETAMIDO-1,2-DIDEOXYNOJIRMYCIN	A	2VC9	0.71
HMN	2,4,6,7,8,9-HEXAHYDROXY-5-METHYLCARBOXAMIDO NONANOIC ACID	A,B,C,D	1F73	0.72
CHK	6-[(CYCLOHEXYLACETYL)(2-HYDROXYETHYL)AMINO]-6-DEOXY-D-XYLO-HEXITOL	B	1Y01	0.7
NXD	METHYL 5-(ACETYLAMINO)-9-{[AMINO(OXO)ACETYL]AMINO}-3,5,9-TRIDEOXY-D-GLYCERO-ALPHA-D-GLUCO-NON-2-ULOPYRANOSIDONIC ACID	A	2G5R	0.72
2G0	(2S)-1-[(2S)-6-amino-2-({[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl]acetyl}amino)hexanoyl]-N-[(1S)-1-carbamoyl-3-methylbutyl]pyrrolidine-2-carboxamide	A,B,C,D	3DCQ	0.77
AMK	(S)-4-AMINO-4-{(S)-1-[(S)-2-CARBAMOYL-1-((S)-1-{(S)-[(1R,2R)-2-((S)-1-CARBOXY-ETHYLCARBAMOYL)-CYCLOPENTYL]-HYDROXY-METHYL}-3-METHYL-BUTYLCARBAMOYL)-ETHYLCARBAMOYL]-2-METHYL-PROPYLCARBAMOYL}-BUTYRIC ACID	A,B,C	1YM4	0.71
DYH	(2R,3aR,6S,7R,7aR)-2-[(2S)-2-amino-2-carboxyethyl]-6-hydroxy-7-(methylamino)hexahydro-2H-furo[3,2-b]pyran-2-carboxylic acid	A	2ZNT	0.71
DYH	(2R,3aR,6S,7R,7aR)-2-[(2S)-2-amino-2-carboxyethyl]-6-hydroxy-7-(methylamino)hexahydro-2H-furo[3,2-b]pyran-2-carboxylic acid	A,B,C,D	3GBA	0.71